Based on the Innate Pharma stock forecast from 3 analysts, the average analyst target price for Innate Pharma is USD 10.42 over the next 12 months. Innate Pharma’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Innate Pharma is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, Innate Pharma’s stock price was USD 1.95. Innate Pharma’s stock price has changed by -2.50% over the past week, +7.14% over the past month and -21.37% over the last year.
No recent analyst target price found for Innate Pharma
No recent average analyst rating found for Innate Pharma
Company Overview Innate Pharma
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Innate Pharma (IPHA)
Loading...
Unadjusted Closing Price for Innate Pharma (IPHA)
Loading...
Share Trading Volume for Innate Pharma Shares
Loading...
Compare Performance of Innate Pharma Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for IPHA
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Innate Pharma (Sector: Biotechnology )
Frequently Asked Questions About Innate Pharma (IPHA) Stock
Based on ratings from 3 analysts Innate Pharma's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 6 buy, sell and hold ratings.
Unfortunately we do not have enough data on IPHA's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for IPHA is USD 10.42 over the next 12 months. The maximum analyst target price is USD 11.5 while the minimum anlayst target price is USD 5.
Unfortunately we do not have enough data on IPHA's stock to indicate if its overvalued.
The last closing price of IPHA's stock was USD 1.95.
Unfortunately we do not currently have any market capitalization data for IPHA's stock.
Based on targets from 3 analysts, the average taret price for IPHA is projected at USD 10.42 over the next 12 months.
This means that IPHA's stock price may go up by +434.19% over the next 12 months.
We can't find any ETFs which contains Innate Pharma's stock.
Sorry, we do not have any data on the number of employees for Innate Pharma.
Sorry we do not have any infomation available on Innate Pharma's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Innate Pharma (IPHA) Stock
Based on ratings from 3 analysts Innate Pharma's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 6 buy, sell and hold ratings.
Unfortunately we do not have enough data on IPHA's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for IPHA is USD 10.42 over the next 12 months. The maximum analyst target price is USD 11.5 while the minimum anlayst target price is USD 5.
Unfortunately we do not have enough data on IPHA's stock to indicate if its overvalued.
The last closing price of IPHA's stock was USD 1.95.
Unfortunately we do not currently have any market capitalization data for IPHA's stock.
Based on targets from 3 analysts, the average taret price for IPHA is projected at USD 10.42 over the next 12 months.
This means that IPHA's stock price may go up by +434.19% over the next 12 months.
We can't find any ETFs which contains Innate Pharma's stock.
Sorry, we do not have any data on the number of employees for Innate Pharma.
Sorry we do not have any infomation available on Innate Pharma's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for IPHA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
